Artelo Biosciences, Inc. (ARTL)
3.11
-0.15
(-4.60%)
USD |
NASDAQ |
Oct 12, 16:00
3.10
-0.01
(-0.32%)
After-Hours: 20:00
Artelo Biosciences Market Cap : 13.03M for Oct. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 12, 2026 | 13.03M |
| October 09, 2026 | 13.65M |
| October 08, 2026 | 14.11M |
| October 07, 2026 | 14.28M |
| October 06, 2026 | 14.49M |
| October 05, 2026 | 14.70M |
| October 02, 2026 | 15.41M |
| October 01, 2026 | 16.04M |
| September 30, 2026 | 16.92M |
| September 29, 2026 | 17.05M |
| September 28, 2026 | 18.01M |
| September 25, 2026 | 19.02M |
| September 24, 2026 | 21.65M |
| September 23, 2026 | 30.62M |
| September 22, 2026 | 17.38M |
| September 21, 2026 | 17.17M |
| September 18, 2026 | 16.50M |
| September 17, 2026 | 16.63M |
| September 16, 2026 | 15.71M |
| September 15, 2026 | 22.37M |
| September 14, 2026 | 20.40M |
| September 11, 2026 | 22.74M |
| September 10, 2026 | 23.58M |
| September 09, 2026 | 25.05M |
| September 08, 2026 | 25.93M |
| Date | Value |
|---|---|
| September 04, 2026 | 25.30M |
| September 03, 2026 | 26.05M |
| September 02, 2026 | 27.31M |
| September 01, 2026 | 25.78M |
| August 31, 2026 | 26.64M |
| August 28, 2026 | 24.98M |
| August 27, 2026 | 24.92M |
| August 26, 2026 | 26.79M |
| August 25, 2026 | 27.04M |
| August 24, 2026 | 25.97M |
| August 21, 2026 | 26.09M |
| August 20, 2026 | 26.85M |
| August 19, 2026 | 27.14M |
| August 18, 2026 | 27.51M |
| August 17, 2026 | 27.18M |
| August 14, 2026 | 29.79M |
| August 13, 2026 | 28.60M |
| August 12, 2026 | 27.63M |
| August 11, 2026 | 28.07M |
| August 10, 2026 | 26.58M |
| August 07, 2026 | 27.18M |
| August 06, 2026 | 28.36M |
| August 05, 2026 | 28.32M |
| August 04, 2026 | 28.84M |
| August 03, 2026 | 28.00M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.691B |
| Corcept Therapeutics, Inc. | 13.08B |
| Veru, Inc. | 41.01M |
| Johnson & Johnson | 635.12B |
| Eli Lilly & Co. | 1.113T |
Market Cap Related Metrics
| Price to Book Value | 2.607 |
| Price | 3.11 |
| Earnings Yield | -739.0% |